Mark Hollywood
CIK 2104446 · View on SEC EDGAR ↗
Insider
First SEC filing: Jan. 13, 2026 · Latest: Jan. 13, 2026
On this page
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net:
$-138,740
+ 6 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
6 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | ZYME | S | 6,120 | $22.67 | $138,740 | 132,913 Direct | -4.40% | Disposed | 22.2% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | ZYME | Performance Stock Unit | Common Stock (66,000) | — | — | 66,000 | Acquired |
| Jan. 12, 2026 | ZYME | Restricted Stock Unit | Common Stock (47,000) | — | — | 47,000 | Acquired |
| Jan. 12, 2026 | ZYME | Stock Option (Right to Buy) | Common Stock (70,000) | $23.16 | Jan. 11, 2036 | 70,000 | Acquired |
| Jan. 12, 2026 | ZYME | Restricted Stock Unit | Common Stock (17,666) | — | — | 17,666 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 10 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 13, 2026 | ZYME | Common Stock | 121,367 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy)→ Common Stock (80,000) | 80,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy)→ Common Stock (24,375) | 24,375 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy)→ Common Stock (30,000) | 30,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy)→ Common Stock (90,000) | 90,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy)→ Common Stock (61,000) | 61,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy)→ Common Stock (90,000) | 90,000 | Direct |
| Jan. 13, 2026 | ZYME | Stock Option (Right to Buy)→ Common Stock (79,000) | 79,000 | Direct |
| Jan. 13, 2026 | ZYME | Restricted Stock Unit→ Common Stock (20,000) | 20,000 | Direct |
| Jan. 13, 2026 | ZYME | Restricted Stock Unit→ Common Stock (53,000) | 53,000 | Direct |